New sleep apnea device hits U.S. market

Tuesday, January 17, 2017

BRISBANE, Australia – Oventus on Jan. 16 announced the U.S. launch of O2Vent, what it calls the first and only sleep disorder device cleared by the Food and Drug Administration that provides relief for snoring and obstructive sleep apnea via a unique, separate airway that avoids multiple sites of obstruction, including the nose, soft palate and the tongue. The device, which uses 3D printing technologies and is customized for each patient from medical-grade titanium, works by stabilizing the jaw position, bringing the tongue forward to reduce airway collapse, according to a press release. Oventus is launching the device first in San Francisco, as part of the G’Day Australia events being held there on Jan. 21.